Clinical Trial Update: Host Dendritic Cells in Allograft Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update from Icahn School of Medicine at Mount Sinai evaluating host dendritic cells in allograft patients for relapsed non-Hodgkin lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Relapsed Non-Hodgkin's Lymphoma, Hodgkin's Disease | Phase 1 | Status: UNKNOWN